Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Australian Ethical Investment Ltd ( (AU:AEF) ) has issued an update.
Australian Ethical Investment Ltd has notified the ASX that it has ceased to be a substantial holder in Australian Clinical Labs Limited, lodging a formal notice confirming its relevant interest in the pathology company’s voting securities fell below the substantial holding threshold on 15 January 2026. The change, documented in a statutory Form 605 and involving State Street Australia Ltd as custodian, signals a reduction in Australian Ethical’s exposure to Australian Clinical Labs and may indicate a portfolio rebalancing or strategic shift in its ethical investment holdings, with potential implications for the shareholder base and trading liquidity of Australian Clinical Labs shares.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$6.00 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.
More about Australian Ethical Investment Ltd
Australian Ethical Investment Ltd is an Australian fund manager and ethical investment firm that manages assets according to environmental, social and governance (ESG) principles, offering ethically screened investment products to retail and institutional investors in the Australian market.
YTD Price Performance: -2.97%
Average Trading Volume: 145,130
Technical Sentiment Signal: Sell
Current Market Cap: A$557.8M
Learn more about AEF stock on TipRanks’ Stock Analysis page.